PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 12, 2026Therapeutic Advances in Neurological Disorders2 citationsOpen Access

Management of tandem occlusions in acute ischaemic stroke

JDJoão H. DuarteMMMariana B. MoraisIFIsabel Fragata

Key Points

  • This review aims to synthesize current evidence regarding the diagnosis, management, and outcomes of tandem occlusions in acute ischaemic stroke.
  • Reviewed existing literature on tandem occlusions in acute ischaemic stroke.
  • Analyzed medical and interventional management strategies such as EVT and carotid artery stenting.
  • Discussed diagnosis challenges and prognostic factors for tandem occlusions.
  • Emergent carotid artery stenting improves outcomes in selected ATOC patients without increasing bleeding risk.
  • Endovascular thrombectomy is effective for both ATOCs and PTOCs, though evidence for PTOCs is limited.
  • Prognosis for ATOCs has improved significantly in the EVT era, while outcomes for PTOCs remain less defined.

Abstract

Intra- and extracranial tandem occlusions (TOCs) in acute ischaemic stroke (AIS) are defined by the coexistence of an intracranial anterior or posterior circulation large vessel occlusion together with an ipsilateral extracranial occlusion or significant stenosis in the corresponding proximal vascular axis. They represent a distinct subgroup of AIS requiring tailored diagnostic and therapeutic strategies and are commonly divided into anterior (ATOCs) and posterior (PTOCs) forms. This narrative review synthesises the current evidence base regarding diagnosis, management (medical and interventional) and prognosis of TOCs. ATOCs account for around 20% of anterior circulation large-vessel occlusions, while PTOCs appear proportionally more frequent in posterior circulation stroke. Atherosclerosis is the predominant mechanism (around 70%), followed by arterial dissection (around 20%–25%), with cardioembolism and rarer causes playing a smaller role. Diagnosis can be challenging, particularly due to pitfalls such as carotid pseudo-occlusion. Endovascular thrombectomy (EVT) is the cornerstone of treatment for TOCs. In ATOCs, emerging evidence suggests that emergent carotid artery stenting improves outcomes in selected patients, with large observational cohorts such as CERES-TANDEM reporting higher functional independence without increased bleeding risk. In PTOCs, EVT is feasible and technically effective, but evidence remains limited. Vertebral stenting may be beneficial in selected cases, though morbidity and mortality remain high. Periprocedural antithrombotic therapy varies widely between centres, and high-quality data are lacking. Bridging therapy with intravenous thrombolysis appears safe and should be performed in eligible patients with tandem lesions. Prognosis has improved substantially for patients with ATOCs in the EVT era, whereas outcomes in PTOCs are less well defined. Continued efforts to generate higher-quality evidence, particularly for PTOCs, will be essential to guide treatment strategies and improve patient outcomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Duarte et al. (2026) studied this question.

synapsesocial.com/papers/698d6eca5be6419ac0d54975https://doi.org/10.1177/17562864251413757
Ask AI
Helpful
Bookmark
Share
View Full Paper